Tryptamine Therapeutics Limited
TYPTF
$0.015
$0.000.00%
| 12/31/2024 | 09/30/2024 | 02/29/2024 | 11/30/2023 | 08/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.78M | 1.99M | 310.10K | 1.52M | 265.30K |
| Total Receivables | 871.80K | 976.70K | 25.50K | 35.70K | 21.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 334.00K | 374.20K | 28.20K | 26.90K | 40.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 28.70K | 23.70K | 28.70K |
| Total Current Assets | 2.98M | 3.34M | 392.50K | 1.61M | 355.90K |
|
|
|||||
| Total Current Assets | 2.98M | 3.34M | 392.50K | 1.61M | 355.90K |
| Net Property, Plant & Equipment | 73.40K | 82.30K | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 220.10K | 246.60K | 126.20K | 126.20K | 126.50K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.40K | 1.50K | -- | -- | -- |
| Total Assets | 3.28M | 3.67M | 518.70K | 1.73M | 482.40K |
|
|
|||||
| Total Accounts Payable | 570.50K | 639.10K | 743.10K | 1.42M | 1.39M |
| Total Accrued Expenses | 54.30K | 60.90K | 36.90K | 22.70K | 66.60K |
| Short-term Debt | 30.80K | 34.50K | 3.91M | 3.69M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 655.60K | 734.50K | 4.69M | 5.13M | 1.46M |
|
|
|||||
| Total Current Liabilities | 655.60K | 734.50K | 4.69M | 5.13M | 1.46M |
| Long-Term Debt | -- | -- | -- | -- | 1.55M |
| Short-term Debt | 30.80K | 34.50K | 3.91M | 3.69M | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 147.00K | 203.60K | 250.50K |
| Total Liabilities | 655.60K | 734.50K | 4.84M | 5.34M | 3.26M |
|
|
|||||
| Common Stock & APIC | 20.09M | 22.51M | 12.58M | 12.56M | 12.58M |
| Retained Earnings | -21.10M | -23.64M | -17.38M | -16.65M | -15.84M |
| Treasury Stock & Other | 3.63M | 4.07M | 482.60K | 482.60K | 483.90K |
| Total Common Equity | 2.62M | 2.94M | -4.32M | -3.60M | -2.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.62M | 2.94M | -4.32M | -3.60M | -2.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.62M | 2.94M | -4.32M | -3.60M | -2.78M |
|
|
|||||
